scholarly journals Association of Benign Paroxysmal Positional Vertigo with Osteoporosis and Vitamin D Deficiency – A Case-Control Study

2018 ◽  
Vol 1 (1-4) ◽  
pp. 2-5
Author(s):  
Kanwar Sen ◽  
B. Vageesh Padiyar ◽  
Geetu Arora
Keyword(s):  
Vitamin D ◽  
Vitamin D Deficiency ◽  
Benign Paroxysmal Positional Vertigo ◽  
Case Control Study ◽  
Case Control ◽  
Positional Vertigo ◽  
Control Study ◽  
Paroxysmal Positional Vertigo

Serum otolin-1 as a biomarker for benign paroxysmal positional vertigo: a case-control study

2021 ◽  
pp. 1-4
Author(s):  
D V K Irugu ◽  
A Singh ◽  
H Yadav ◽  
H Verma ◽  
R Kumar ◽  
...  
Keyword(s):  
Serum Level ◽  
Benign Paroxysmal Positional Vertigo ◽  
Case Control Study ◽  
Serum Levels ◽  
Case Control ◽  
Control Group ◽  
Positional Vertigo ◽  
The Difference ◽  
Control Study ◽  
Paroxysmal Positional Vertigo

Abstract Objectives This study aimed to evaluate serum otolin-1 levels in patients with benign paroxysmal positional vertigo and to compare these levels with healthy individuals. Method This was a case-control study. After obtaining institutional ethical committee clearance, the serum level of otolin-1 was calculated in adult individuals (18–75 years old) who were divided into group 1 (patients presenting with benign paroxysmal positional vertigo) and group 2 (healthy patients without benign paroxysmal positional vertigo as the control group). Data analysis was carried out to compare the serum levels in the cases and controls. A p-value less than 0.05 was considered significant. Results A total of 70 age-matched individuals (cases, n = 40; controls, n = 30) were included in the study. The mean serum level of otolin-1 was 636.8 pg/ml (range, 259–981 pg/ml) in the group of patients with benign paroxysmal positional vertigo and 236.2 pg/ml (range, 189–370 pg/ml) in the control group. The difference was statistically significant (p = 0.0000). Conclusion The serum levels of otolin-1 in patients with benign paroxysmal positional vertigo are significantly higher compared with individuals without benign paroxysmal positional vertigo.

scholarly journals Benign Paroxysmal Positional Vertigo after Dental Procedures: A Population-Based Case-Control Study

PLoS ONE ◽  
2016 ◽  
Vol 11 (4) ◽  
pp. e0153092 ◽  
Author(s):  
Tzu-Pu Chang ◽  
Yueh-Wen Lin ◽  
Pi-Yu Sung ◽  
Hsun-Yang Chuang ◽  
Hsien-Yang Chung ◽  
...  
Keyword(s):  
Benign Paroxysmal Positional Vertigo ◽  
Case Control Study ◽  
Population Based ◽  
Case Control ◽  
Positional Vertigo ◽  
Dental Procedures ◽  
Control Study ◽  
Paroxysmal Positional Vertigo

Dose–response association between vitamin D deficiency and atopic dermatitis in children, and effect modification by gender: a case-control study

2019 ◽  
pp. 1-6
Author(s):  
Amal Ahmed Mohamed ◽  
Eman Mohamed Salah Ahmed ◽  
Youssef M. K. Farag ◽  
Nermeen Ibrahim Bedair ◽  
Nourelhuda Ahmed Nassar ◽  
...  
Keyword(s):  
Vitamin D ◽  
Atopic Dermatitis ◽  
Vitamin D Deficiency ◽  
Dose Response ◽  
Case Control Study ◽  
Case Control ◽  
Effect Modification ◽  
Control Study

scholarly journals Correlation Between 25-hydroxy-Vitamin D and Parkinson's Disease:A Case-Control study

2020 ◽  
Author(s):  
ming xia ◽  
wenjuan Xiu ◽  
Xuliang Wang ◽  
Tingting Wu ◽  
Yingying Zheng ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Vitamin D ◽  
Parkinson's Disease ◽  
Vitamin D Deficiency ◽  
Case Control Study ◽  
Case Control ◽  
Lower Serum ◽  
Vitamin D Levels ◽  
25 Hydroxy Vitamin D ◽  
Control Study

Abstract Background: Previous cross-sectional studies have shown that Parkinson’s disease (PD) patients have lower serum 25- hydroxy vitamin D (25(OH)D) concentrations than controls. whether the research in other regions findings are generalizable to China populations remains untested in other studies. In this case-control study we examined the Correlation between 25-hydroxy-vitamin D and Parkinson's disease.Methods:We establish an association between deficiency of 25-hydroxy-vitamin D and PD in a case-control study of 100 PD patients and 100 control subjects free of neurologic disease in the First Affliated Hospital of Xinjiang Medical University.Results:Total 25-hydroxy-vitamin D levels, were deficient in 21% of patients with PD compared with 4% of controls. In univariate analyses Plasma levels of 25-hydroxy-vitamin D were associated with PD(p<0.001), respectively. In multivariate analyses, Vitamin D deficiency(25(OH)D <20 ng/mL) were significant associated with PD (p=0.008,OR=17.13,95% CI, 2.082-141.075). Individuals with levels in the lowest quartile of 25(OH)D values had the highest prevalence of PD(p =0.026,OR=11.786,95%CI,1.342-103.51)compared with individuals with values in the highest quartile.Conclusions:Our study reveals an association between 25-hydroxy-vitamin D and PD.Patients with incident PD had significantly lower serum 25(OH)D concentrations than age-matched controls, High-risk PD patients with vitamin D deficiency who have not yet developed exercise impairment, these populations should undergo vitamin D measurement and vitamin D treatment as soon as possible.

Sign in / Sign up

Export Citation Format

Share Document